placeholder image
J. K. Mader All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Continuous glucose monitoring data analysis 2.0: functional data pattern recognition and artificial intelligence applications. 
    Journal of Diabetes Science and Technology. 2025
  • Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1. 
    The lancet. Diabetes & endocrinology. 2024
  • The Diabetes Technology Society error grid and trend accuracy matrix for glucose monitors. 
    Journal of Diabetes Science and Technology. 2024
  • Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes. 
    Diabetes Therapy. 2021
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Pediatric Diabetes. 2020
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Diabetologia. 2020
  • A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes. 
    Diabetes care. 2014
    • Editorial Article
  • Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations [editorial]?. 
    Diabetologia.  64. 2021
  • Duration of hybrid closed-loop insulin therapy to achieve representative glycemic outcomes in adults with type 1 diabetes [editorial]. 
    Diabetes care.  43. 2020
    • Conference Poster
  • Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]
    2019
  • Optimal sampling duration of hybrid closed-loop therapy to determine long-term glycemic control in adults with type 1 diabetes [poster]
    2019
    • Contact
    full name
  • J. K. Mader
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration